$0.37
2.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 11
Data gathered: December 11
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | N/A | N/A |
| Sentiment | N/A | N/A |
| Webpage traffic | N/A | N/A |
| Employee Rating | N/A | N/A |
| Google Adspend | $ N/A | N/A |
| Google Trends | N/A | N/A |
| Linkedin Employees | N/A | N/A |
| Patents | N/A | N/A |
| 4chan Mentions | N/A | N/A |
| Facebook Engagement | N/A | N/A |
| Facebook followers | N/A | N/A |
| Stocktwits Mentions | N/A | N/A |
| Stocktwits Subscribers | N/A | N/A |
| Twitter Followers | N/A | N/A |
| Youtube Subscribers | N/A | N/A |
| News Mentions | N/A | N/A |
| Reddit Mentions | N/A | N/A |
| ESG | N/A | N/A |
| Business outlook | N/A | N/A |
In the news
 |
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading dayDecember 8 - MarketWatch |
 |
Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews.comDecember 7 - ETF Daily News |
|
Inovio Pharmaceuticals Inc. stock outperforms competitors despite losses on the dayDecember 7 - MarketWatch |
|
Inovio Pharmaceuticals Inc. stock falls Wednesday, underperforms marketDecember 6 - MarketWatch |
Inovio management to meet with OppenheimerDecember 5 - Thefly.com |
|
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving PremarketDecember 4 - Benzinga |
|
About Inovio Pharmaceuticals
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
| Price | $0.37 |
| Target Price | Sign up |
| Market Cap | $104M |
| Dividend Yield | 0.0152 |
| Industry | Biotechnology |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 2M | 20M | -18M | -34M | -36M |
| Q2 '23 | 2.1M | 14M | -11M | -36M | -37M |
| Q1 '23 | 110,000 | 14M | -15M | -41M | -44M |
| Q4 '22 | 120,000 | 14M | -16M | -54M | -56M |
| Q3 '22 | 10M | 12M | -1.7M | -38M | -36M |
Insider Transactions
| Zoth Lota S. filed to sell 52,716 shares at $0.6. June 5 '23 |
| Weiner David B. filed to sell 910,124 shares at $1.2. March 13 '23 |
| Weiner David B. filed to sell 904,291 shares at $1.3. February 28 '23 |
| Weiner David B. filed to sell 892,625 shares at $2.7. August 11 '22 |
| BENITO SIMON X filed to sell 75,305 shares at $2.3. July 20 '22 |
Read more about Inovio Pharmaceuticals and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, reddit mentions, esg, business outlook.